Aldeyra Therapeutics, Inc.
Nasdaq · CIK 0001341235 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | Aldeyra Therapeutics, Inc. | 2026-06-05 | 0001193125-26-259637 |
| 10-Q | Aldeyra Therapeutics, Inc. | 2026-05-07 | 0001341235-26-000006 |
| 4 | Aldeyra Therapeutics, Inc. | 2026-03-20 | 0001193125-26-117675 |
| 4 | Aldeyra Therapeutics, Inc. | 2026-03-19 | 0001193125-26-116247 |
| 10-K | Aldeyra Therapeutics, Inc. | 2026-02-27 | 0001193125-26-083012 |
| 10-Q | Aldeyra Therapeutics, Inc. | 2025-11-05 | 0001193125-25-266989 |
| 4 | Aldeyra Therapeutics, Inc. | 2025-08-15 | 0000950170-25-109391 |
| 4 | Aldeyra Therapeutics, Inc. | 2025-08-13 | 0000950170-25-108210 |
| 10-Q | Aldeyra Therapeutics, Inc. | 2025-08-07 | 0000950170-25-104971 |